Details of the Drug

General Information of Drug (ID: DM2MQ1P)

• Drug Name: Tumor infiltrating lymphocyte

Indication

Disease Entry	ICD 11	Status	REF
Melanoma	2C30	Phase 2	[1]

• Cross-matching ID: TTD ID: D0H8DS

References

• [1] Clinical pipeline report, company report or official report of Lion biotechnologies.